自然产品衍生药物的纳米颗粒:超越了流行病
1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia.
Heliyon
|March 14, 2025
概括
自然产品和纳米技术提供了对抗病毒感染的协同潜力,增强免疫反应和抗氧化物质的特性,以对抗流行病. 这种方法可以提高传统药物对新出现的病毒威胁的疗效.
科学领域:
- 病毒学 病毒学
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 流行性病毒感染构成严重的公共卫生危机,病毒突变和有限的治疗选择加剧了这种危机.
- 细胞因子风暴是一种全身炎症反应,导致高死亡率,特别是在脆弱人群中.
- 随着COVID-19的流行,人们对天然产品衍生的抗病毒药物和传统医学疗效的兴趣越来越大.
研究的目的:
- 探索自然产品与纳米技术相结合的协同潜力,用于对抗病毒感染.
- 突出天然产品对抗流行病毒的抗病毒,免疫调节和抗氧化特性.
- 检查纳米技术如何提高草药在治疗病毒性疾病中的有效性.
主要方法:
- 对抗病毒研究中的天然产品和纳米技术现有文献的审查.
- 分析天然产品的药理性质,包括抗病毒,免疫调节,抗炎和抗氧化作用.
- 对天然产品化合物的基于纳米技术的输送系统的研究.
主要成果:
- 自然产品表现出显著的抗病毒,免疫调节和抗氧化活性,有利于大流行控制.
- 纳米技术提高了天然产品衍生抗病毒药物的生物可用性,稳定性和有针对性的输送.
- 与单个成分相比,天然产品和纳米技术的协同效应组合显示出对病毒感染的有效性有所提高.
结论:
- 自然产品和纳米技术的整合为开发抗病毒流行病的新疗法提供了一个有前途的战略.
- 增强的输送系统可以克服传统草药的局限性,改善其治疗结果.
- 对这种协同方法的进一步研究对于未来的流行病准备和应对至关重要.
相关概念视频
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.